1. Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance. Ayala JE, Bracy DP, James FD, Burmeister MA, Wasserman DH, Drucker DJ (2010) Endocrinology 151(10): 4678-87
    › Primary publication · 20685876 (PubMed) · PMC2946144 (PubMed Central)
  2. Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo. Lee-Young RS, Ayala JE, Hunley CF, James FD, Bracy DP, Kang L, Wasserman DH (2010) Am J Physiol Regul Integr Comp Physiol 298(5): R1399-408
    › Primary publication · 20200137 (PubMed) · PMC2867517 (PubMed Central)
  3. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Ayala JE, Bracy DP, James FD, Julien BM, Wasserman DH, Drucker DJ (2009) Endocrinology 150(3): 1155-64
    › Primary publication · 19008308 (PubMed) · PMC2654733 (PubMed Central)
  4. Skeletal muscle AMP-activated protein kinase is essential for the metabolic response to exercise in vivo. Lee-Young RS, Griffee SR, Lynes SE, Bracy DP, Ayala JE, McGuinness OP, Wasserman DH (2009) J Biol Chem 284(36): 23925-34
    › Primary publication · 19525228 (PubMed) · PMC2781986 (PubMed Central)
  5. Metabolic implications of reduced heart-type fatty acid binding protein in insulin resistant cardiac muscle. Shearer J, Fueger PT, Wang Z, Bracy DP, Wasserman DH, Rottman JN (2008) Biochim Biophys Acta 1782(10): 586-92
    › Primary publication · 18692568 (PubMed)
  6. Insulin action in the double incretin receptor knockout mouse. Ayala JE, Bracy DP, Hansotia T, Flock G, Seino Y, Wasserman DH, Drucker DJ (2008) Diabetes 57(2): 288-97
    › Primary publication · 17977951 (PubMed)
  7. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Fueger PT, Lee-Young RS, Shearer J, Bracy DP, Heikkinen S, Laakso M, Rottman JN, Wasserman DH (2007) Diabetes 56(10): 2476-84
    › Primary publication · 17639019 (PubMed)
  8. Glucose kinetics and exercise tolerance in mice lacking the GLUT4 glucose transporter. Fueger PT, Li CY, Ayala JE, Shearer J, Bracy DP, Charron MJ, Rottman JN, Wasserman DH (2007) J Physiol 582(Pt 2): 801-12
    › Primary publication · 17495042 (PubMed) · PMC2075340 (PubMed Central)
  9. Chronic treatment with sildenafil improves energy balance and insulin action in high fat-fed conscious mice. Ayala JE, Bracy DP, Julien BM, Rottman JN, Fueger PT, Wasserman DH (2007) Diabetes 56(4): 1025-33
    › Primary publication · 17229936 (PubMed)
  10. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH (2006) Diabetes 55(2): 390-7
    › Primary publication · 16443772 (PubMed)